The other subsidiaries were part of the sell, but Humanigen Australia needed to survive the consolidation to merge with Taran, which I believe will provide me the opportunity to sell part of my holdings for $200 per share, and which will also reunite the share structure with the ownership of the IP.
Before that, I think we'll actually see the bankruptcy discharged with the modified share structure intact.